Showing results (111-120 of 158) with videos related to

Sort By:
Pageof 16
The Patient|March 24, 2022
Perspectives of Pediatric Rheumatologists on Initiating and Tapering Biologics in Patients with Juvenile Idiopathic Arthritis: A Formative Qualitative StudyGillian R Currie, Tram Pham, Marinka Twilt, et al.
The Journal of Rheumatology|January 6, 2006
Old challenges and new directions in pediatric rheumatologyDavid A Cabral, Ron M Laxer, John Schrader, et al.
Arthritis Care & Research|May 3, 2021
Costs of Hospital-Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care SystemMichelle M A Kip, Sytze de Roock, Inge van den Berg, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 27, 2020
Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare systemMichelle M A Kip, Sytze de Roock, Gillian Currie, et al.
Pharmacoeconomics|April 7, 2023
Developing a Framework of Cost Elements of Socioeconomic Burden of Rare Disease: A Scoping ReviewGillian R Currie, Brittany Gerber, Diane Lorenzetti, et al.
Arthritis Research & Therapy|March 21, 2020
A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of careClaire E H Barber, Marinka Twilt, Tram Pham, et al.
Pediatric Rheumatology Online Journal|July 23, 2022
Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritisLuiza R Grazziotin, Gillian Currie, Marinka Twilt, et al.
Rheumatology and Therapy|July 18, 2021
Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort StudyLuiza R Grazziotin, Gillian Currie, Marinka Twilt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 24, 2021
Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic PolyangiitisPaul Brogan, Rae S M Yeung, Gavin Cleary, et al.
Pediatric Rheumatology Online Journal|July 11, 2023
Withdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists?Janine A van Til, Michelle M A Kip, Ellen J H Schatorjé, et al.
Pageof 16